Vitamin D Study Hints at Long COVID Relief

Scientists at Mass General Brigham just uncovered an unexpected bright spot in the fight against long COVID, and it might be sitting in your medicine cabinet.

The VIVID trial enrolled nearly 2,000 people across the United States and Mongolia who had recently tested positive for COVID-19. Half received high doses of vitamin D3, while the other half got a placebo for four weeks.

The initial results weren't what researchers hoped for. Vitamin D didn't reduce hospitalizations, emergency room visits, or how sick people felt during their infections. It also didn't stop the virus from spreading to household members.

But when scientists looked eight weeks later, they noticed something intriguing. Among participants who stuck with their vitamin D regimen, only 21% reported lingering symptoms compared to 25% in the placebo group.

That four percentage point difference might sound small, but it caught the attention of lead researcher Dr. JoAnn Manson. Long COVID affects millions of people worldwide, causing exhausting symptoms like brain fog, fatigue, and shortness of breath that can last for months or years.

The trial was one of the largest and most carefully designed studies of vitamin D and COVID-19 to date. Participants started taking supplements about three days after testing positive, receiving 9,600 IU daily for two days, then 3,200 IU daily after that.

Researchers took extra care to ensure fair comparisons between groups. They balanced factors like age, weight, vaccination status, and ethnicity that could influence outcomes.

The Bright Side

While vitamin D won't prevent COVID infections or reduce initial symptoms, this finding opens a new door for long COVID research. The condition has puzzled doctors and devastated patients since the pandemic began, with few proven treatments available.

The study's timing matters too. It ran from December 2020 through September 2022 in the U.S., capturing data across different COVID variants and vaccination rates. That real-world diversity makes the results more meaningful.

Dr. Manson emphasized that the long COVID signal, while promising, was only borderline statistically significant. Her team wants to conduct larger studies specifically focused on whether long-term vitamin D supplementation could help prevent or ease persistent symptoms.

For now, vitamin D remains a safe, affordable supplement that many people already take for bone health and immune support. This research suggests it might offer an extra benefit researchers never anticipated when they designed the trial.

The journey to understanding long COVID continues, but this study adds another piece to the puzzle.